A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia - PubMed (original) (raw)

. 2008 Apr;101(1-3):9-16.

doi: 10.1016/j.schres.2008.01.027. Epub 2008 Mar 10.

Minori Koga, Hiroki Ishiguro, Yasue Horiuchi, Makoto Arai, Kazuhiro Niizato, Masanari Itokawa, Toshiya Inada, Nakao Iwata, Shyuji Iritani, Norio Ozaki, Hiroshi Kunugi, Hiroshi Ujike, Yuichiro Watanabe, Toshiuki Someya, Tadao Arinami

Affiliations

• PMID: 18329248
• DOI: 10.1016/j.schres.2008.01.027

Free article

A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia

Tsuyuka Ohtsuki et al. Schizophr Res. 2008 Apr.

Free article

Abstract

Introduction: Glutamate dysfunction has been implicated in the pathophysiology of schizophrenia. The metabotropic glutamate receptors (mGluRs) are G-protein-coupled receptors. GRM7, the gene that encodes mGluR7, is expressed in many regions of the human central nervous system. The GRM7 gene is located on human chromosome 3p26, which has been suggested by linkage analysis to contain a susceptibility locus for schizophrenia.

Methods: We screened for mutations in all exons, exon/intron junctions, and promoter regions of the GRM7 gene in Japanese patients with schizophrenia and evaluated associations between the detected polymorphisms and schizophrenia. We examined the influence of one polymorphism associated with schizophrenia on the expression of GRM7 by dual-luciferase assay in transfected cells.

Results: Twenty-five polymorphisms/mutations were detected in GRM7. Case-control analysis revealed a potential association of a synonymous polymorphism (371T/C, rs3749380) in exon 1 with schizophrenia in our case-control study of 2293 Japanese patients with schizophrenia and 2382 Japanese control subjects (allelic p=0.009). Dual-luciferase assay revealed suppression of transcription activity by exon 1 containing this polymorphism and a statistically significant difference in the promoter activity between the T and C alleles.

Conclusions: Our results support the possible association of a GRM7 gene polymorphism with genetic susceptibility to schizophrenia.

PubMed Disclaimer

Similar articles

• Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia.
  Shibata H, Tani A, Chikuhara T, Kikuta R, Sakai M, Ninomiya H, Tashiro N, Iwata N, Ozaki N, Fukumaki Y. Shibata H, et al. Psychiatry Res. 2009 May 15;167(1-2):88-96. doi: 10.1016/j.psychres.2007.12.002. Epub 2009 Apr 7. Psychiatry Res. 2009. PMID: 19351574
• GRM7 polymorphisms and risk of schizophrenia in Iranian population.
  Azari I, Moghadam RH, Fallah H, Noroozi R, Ghafouri-Fard S, Taheri M. Azari I, et al. Metab Brain Dis. 2019 Jun;34(3):847-852. doi: 10.1007/s11011-018-0380-6. Epub 2019 Jan 4. Metab Brain Dis. 2019. PMID: 30610437
• Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample.
  Park S, Jung SW, Kim BN, Cho SC, Shin MS, Kim JW, Yoo HJ, Cho DY, Chung US, Son JW, Kim HW. Park S, et al. Behav Brain Funct. 2013 Jan 7;9:1. doi: 10.1186/1744-9081-9-1. Behav Brain Funct. 2013. PMID: 23295062 Free PMC article.
• GRM7 gene mutations and consequences for neurodevelopment.
  Freitas GA, Niswender CM. Freitas GA, et al. Pharmacol Biochem Behav. 2023 Apr;225:173546. doi: 10.1016/j.pbb.2023.173546. Epub 2023 Mar 30. Pharmacol Biochem Behav. 2023. PMID: 37003303 Free PMC article. Review.
• The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia.
  Maj C, Minelli A, Giacopuzzi E, Sacchetti E, Gennarelli M. Maj C, et al. Curr Neuropharmacol. 2016;14(5):540-50. doi: 10.2174/1570159x13666150514232745. Curr Neuropharmacol. 2016. PMID: 27296644 Free PMC article. Review.

Cited by

• Glutamate receptor genetic variants affected peripheral glutamatergic transmission and treatment induced improvement of Indian ADHD probands.
  Chatterjee M, Saha S, Shom S, Dutta N, Sinha S, Mukhopadhyay K. Chatterjee M, et al. Sci Rep. 2023 Nov 14;13(1):19922. doi: 10.1038/s41598-023-47117-5. Sci Rep. 2023. PMID: 37964012 Free PMC article.
• G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders.
  Wong TS, Li G, Li S, Gao W, Chen G, Gan S, Zhang M, Li H, Wu S, Du Y. Wong TS, et al. Signal Transduct Target Ther. 2023 May 3;8(1):177. doi: 10.1038/s41392-023-01427-2. Signal Transduct Target Ther. 2023. PMID: 37137892 Free PMC article. Review.
• An atlas of regulatory elements in chicken: A resource for chicken genetics and genomics.
  Pan Z, Wang Y, Wang M, Wang Y, Zhu X, Gu S, Zhong C, An L, Shan M, Damas J, Halstead MM, Guan D, Trakooljul N, Wimmers K, Bi Y, Wu S, Delany ME, Bai X, Cheng HH, Sun C, Yang N, Hu X, Lewin HA, Fang L, Zhou H. Pan Z, et al. Sci Adv. 2023 May 3;9(18):eade1204. doi: 10.1126/sciadv.ade1204. Epub 2023 May 3. Sci Adv. 2023. PMID: 37134160 Free PMC article.
• The Role of Glutamatergic Gene Polymorphisms in the Clinical Phenotypes of Schizophrenia.
  Poltavskaya EG, Kornetova EG, Freidin MB, Pozhidaev IV, Paderina DZ, Bocharova AV, Semke AV, Bokhan NA, Ivanova SA, Fedorenko OY. Poltavskaya EG, et al. Genes (Basel). 2023 Feb 24;14(3):575. doi: 10.3390/genes14030575. Genes (Basel). 2023. PMID: 36980845 Free PMC article.
• Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease.
  Luessen DJ, Conn PJ. Luessen DJ, et al. Pharmacol Rev. 2022 Jul;74(3):630-661. doi: 10.1124/pharmrev.121.000540. Pharmacol Rev. 2022. PMID: 35710132 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • CORE
  • ClinicalKey
  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information